This inventor holds 3 USPTO granted patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2006-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2011
Title: The Innovative Contributions of Sarah M. Russell
Introduction
Sarah M. Russell is a prominent inventor based in Kensington, MD (US). She has made significant contributions to the field of immunology, particularly through her work on Janus family kinases. With a total of 3 patents to her name, her research has the potential to impact therapeutic approaches for immune modulation.
Latest Patents
Among her latest patents is the development of an isolated polynucleotide that encodes the JAK-3 protein. This protein is a protein tyrosine kinase with a molecular weight of approximately 125 kDa. It features tandem non-identical catalytic domains and notably lacks SH2 or SH3 domains. JAK-3 is expressed in natural killer (NK) cells and stimulated or transformed T cells, but not in resting T cells. The patent also includes the protein itself and antibodies to this protein. Furthermore, methods for identifying therapeutic agents that modulate the immune system are outlined in her work.
Career Highlights
Sarah M. Russell is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her role at this esteemed institution allows her to engage in groundbreaking research that contributes to the understanding of immune responses and potential treatments.
Collaborations
Throughout her career, Sarah has collaborated with notable colleagues, including John J. O'Shea and Warren Jaye Leonard. These partnerships have further enriched her research and expanded the impact of her innovations.
Conclusion
Sarah M. Russell's work exemplifies the intersection of innovation and healthcare. Her contributions to the understanding of immune modulation through her patents are invaluable. As she continues her research, her findings may lead to significant advancements in therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile